Effect of a matrix metalloproteinase inhibitor on host resistance against Listeria monocytogenes infection

FEMS Immunology and Medical Microbiology

Volumn 29, Issue 3, 2000, Pages 187-194

  Yamada, Kyogo ^a   Yoshino, Kohichiro ^b   Sekikawa, Kenji ^c   Madarame, Hiroo ^d   Yagita, Hideo ^e   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b KANEBO LTD   (Japan)

^c NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^d AZABU UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

Author keywords

Endotoxin shock; Listeria monocytogenes; Matrix metalloproteinase; Tumor necrosis factor

Indexed keywords

[4 (N HYDROXYAMINO) 2 ISOBUTYL 3 METHYLSUCCINYL]PHENYLGLYCINE N METHYLAMIDE; [4 (N HYDROXYAMINO) ISOBUTYL METHYLSUCCINYL] PHENYLGLYCINE N METHYLAMIDE; FAS LIGAND; MATRIX METALLOPROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITOR COMPLEX; FEMALE; GRAFT VERSUS HOST REACTION; HOST RESISTANCE; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; COLONY COUNT, MICROBIAL; FAS LIGAND PROTEIN; FEMALE; GLYCINE; HYDROXAMIC ACIDS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; LISTERIA INFECTIONS; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PROTEASE INHIBITORS; SHOCK, SEPTIC; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034605747     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00204-2     Document Type: Article

References (40)

1. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
2. Biology of tumour metastasis
3. Extracellular matrix 6: Role of matrix metalloproteinases in tumour invasion and metastasis
4. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
5. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotropic model in nude mice
6. Marimastat, a novel matrix metalloproteinase inhibitor in patients with hormone-refractory prostate cancer
7. Marimastat, a novel matrix metalloproteinase inhibitor in patients with advanced cancer of the ovary
8. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
9. Processing of tumour necrosis factor-α precursor by metalloproteinase inhibitor
10. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
11. A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice
12. Involvement of 26-kDa cell-associated TNF-α in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor
13. Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors
14. Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-α processing
15. A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic bone marrow transplantation
16. A metalloproteinase inhibitor prevents acute graft-versus-host disease after bone marrow transplantation
17. Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice
18. Production of tumor necrosis factor during murine listeriosis
19. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection
20. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice
21. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes infection
22. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
23. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
24. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor
25. Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance
26. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor α-deficient mice
27. Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in gamma interferon-depleted mice
28. Polymorphism of murine Fas ligand that affects the biological activity
29. Host resistance against Listeria monocytogenes is reciprocal during the course of infection in alymphoplastic aly mutant mice
30. Endogenous cytokines during a lethal infection with Listeria monocytogenes in mice
31. CD95 (Fas) may control the expansion of activated T cells after elimination of bacteria in murine listeriosis
32. Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes
33. + T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-γ but requires TNF-α
34. + T cells through IL-12 produced by Listeria-induced macrophages
35. Immune response in mice that lack the interferon-γ receptor
36. Disparate roles for TNF-α and Fas ligand in concanavalin A induced hepatitis
37. Natural immunity: A T-cell independent pathway of macrophage activation, defined in the scid mouse
38. Interleukin 12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist
39. Immunity to intracellular bacteria
40. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice